Effect Modification of Serum Omega-3 Fatty Acids on the Associations between Urinary Phthalate Biomarkers Mixture and Pregnancy Outcomes among Women Seeking Fertility Care.

BACKGROUND

Phthalate exposures are ubiquitous and have been associated with pregnancy complications. Interaction between serum long-chain n-3 polyunsaturated fatty acids (n3PUFA) and phthalate biomarkers is biologically plausible because both can bind to human peroxisome proliferator-activated receptors (PPARs), which are involved in placenta development. However, evidence of this interaction in humans is lacking.

OBJECTIVE

This study evaluated whether serum n3PUFA modifies the associations of biomarkers of phthalate exposure on pregnancy outcomes.

METHODS

Among 351 women undergoing in vitro fertilization in the Environment and Reproductive Health study (2004-2017), we evaluated the effect modification of eicosapentaenoic acid (EPA) and serum docosahexaenoic acid (DHA) on the association of pregnancy outcomes with the mixture of urinary concentrations of phthalate biomarkers by quantile g-computation. All models were adjusted for age, body mass index, prior smoking, infertility diagnosis, treatment year, and urinary specific gravity.

RESULTS

Concentrations of the phthalate biomarkers mixture were associated with higher adjusted probabilities of pregnancy loss and lower estimated probabilities of live birth among women with serum EPA+DHA in the lowest tertile (<2.66% of total fatty acids), but not among women with middle-to-high serum EPA+DHA (p interactions=0.06 and 0.15, respectively). Among women in the lowest tertile of serum EPA+DHA, the adjusted probability [95% confidence interval (CI)] of pregnancy loss for women in the lowest and highest quartile of phthalates mixtures was 5% (95% CI: 2%, 16%) and 44% (95% CI: 23%, 85%), respectively (p trend=0.01). The corresponding estimates were 14% (95% CI: 5%, 41%) and 11% (95% CI: 3%, 42%) among women with serum EPA+DHA in the highest tertile (≥3.78%  of total fatty acids) (p trend=0.81). Similar trends were observed for live birth but not for implantation and clinical pregnancy.

CONCLUSIONS

This study suggests adverse effects of phthalate exposure on pregnancy loss and live birth may be attenuated by intakes of n3PUFA. These results, if replicated, could inform clinical practice reducing the burden of infertility by phthalate exposure among the general population and improving pregnancy outcomes among subfertile couples. https://doi.org/10.1289/EHP15942.